CCL5 and lung carcinoma: It has been reported that CCL5 could acts through PI3K/Akt, which in turn activates IKKα/β and NF-κB, and contributing to the migration of human lung cancer cells [24], and NF-κB activation could promote the expression of MMP9 [25].